HSP110 expression correlates with c-MYC and Bcl6 protein expression in tumor biopsies of BL, DLBCL, FL, and MCL, and HSP110 knockdown leads to decreases in both oncogenes [23]. This evidence concerns the gene MYC and Burkitt lymphoma.